Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
about
Review of studies mapping from quality of life or clinical measures to EQ-5D: an online databaseAre social security policies for Chinese landless farmers really effective on health in the process of Chinese rapid urbanization? A study on the effect of social security policies for Chinese landless farmers on their health-related quality of lifeMethods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain.Utility scores for different health states related to depression: individual participant data analysis.Predicting preference-based utility values using partial proportional odds modelsLongitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients.Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population.Mapping onto Eq-5 D for patients in poor health.Should linking replace regression when mapping from profile-based measures to preference-based measures?From KIDSCREEN-10 to CHU9D: creating a unique mapping algorithm for application in economic evaluationA comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials.Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients.Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approachesThe clinical and cost effectiveness of group art therapy for people with non-psychotic mental health disorders: a systematic review and cost-effectiveness analysisUsing quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trialEffect of Exposure to Second-Hand Smoke on the Quality of Life: A Nationwide Population-Based Study from South Korea.Mapping Functions in Health-Related Quality of Life: Mapping from Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L.Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the kneeMapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohortMapping the neck disability index to SF-6D in patients with chronic neck painA brief patient-reported outcome instrument for primary care: German translation and validation of the Measure Yourself Medical Outcome Profile (MYMOP).Assessing the external validity of algorithms to estimate EQ-5D-3L from the WOMAC.Estimation of utility values from visual analog scale measures of health in patients undergoing cardiac surgery.Utility estimation in chronic obstructive pulmonary disease: a preference for change?Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire.The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.Does the EQ-5D capture the concerns measured by the Palliative care Outcome Scale? Mapping the Palliative care Outcome Scale onto the EQ-5D using statistical methods.Predicting preference-based SF-6D index scores from the SF-8 health survey.Cost Effectiveness of Characterised Chondrocyte Implantation for Treatment of Cartilage Defects of the Knee in the UK.What Determines the Shape of an EQ-5D Index Distribution?Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL.Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study.The Cost-Effectiveness of Anterior Cruciate Ligament Reconstruction in Competitive Athletes.Does disease activity add to functional disability in estimation of utility for rheumatoid arthritis patients on biologic treatment?Mapping the disease-specific LupusQoL to the SF-6D.Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients.Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.Cost-utility analysis of adjuvant therapies for breast cancer in Iran.Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.
P2860
Q27026613-E3BC56AC-F5C3-4471-8AE6-F550B4C7F3E5Q30392402-7ADC97DD-C98B-4BA5-95A3-1F70DA472A35Q31135481-2E5C8369-F208-469B-8733-5D88A4074726Q33841729-5609E505-1A66-435D-8EB4-EA56913762D4Q33986188-8490BC71-D7FA-4481-988B-4A01F99CC275Q34129848-355827CB-6A9F-4405-BCF7-FA90B68A49BCQ34304052-ECB0E474-CE17-4375-9C9F-78A8ED3B5330Q34408145-D082EC78-4ABC-465A-BBD0-BA93FDD7B7ECQ34516058-9CEE1F5E-896A-42D8-84D5-8EB63A1F1FA1Q34570162-E10FB39E-A8B8-458C-9F84-0E7D58E2945EQ34981168-07A48725-3D23-4DD4-B492-64A59A828B8CQ35148246-33521BBA-5434-48CB-A86D-B58DA17E36A6Q35189500-F60179D7-4DD7-4ABB-AF9E-E87F45FFEAE4Q35684625-1748A1D2-7149-4565-ADC2-E449A7E9B23AQ35705716-EE522572-BAE6-4E24-BF06-EE47957B8E86Q35783700-F49BA006-42B6-4009-B59C-C26992FB2EF8Q36070909-B321ABE6-F0C1-4A41-94F4-F0DA13F0FD36Q36127240-569CB46A-B8B0-48FD-8C83-40A42115DD40Q36299326-558F9954-F1B2-406C-B46F-1646CB5C513DQ36557998-0B0EF52E-B3A1-4ED1-9152-96DBB5B89C36Q36583657-E3531D95-88C5-4FC8-8C99-DED0F3928A3EQ37233022-760478B9-0D68-4D0F-8239-D37201E0A333Q37311129-E72EFDF0-A2D5-4714-9B9F-129D9D4ABE90Q37487742-5A03FB9C-EB48-4CD4-81B2-705A52240370Q37944316-7C44565B-D160-43EB-9537-A0BC529BD7E3Q38068462-E63CB3AF-1226-435F-A125-59E37C6AB207Q38558706-6FB114EC-F710-4CE9-A7E5-FC43A4A39179Q38824501-69F848F4-4CF9-4826-AA93-F92695F70482Q39538688-E6B6A5E4-4C1E-4CAB-9B0B-99D6F9A6A8C1Q39672666-6F7DF44C-97AC-4315-9BBA-7CD9C36BAB13Q39823223-DCA9F5EB-327C-495B-84C4-35D5BBCDFEF2Q39835587-6CCB3A41-D5A4-4E38-9216-DB811F9A5A3FQ40402410-4F5B886F-E17E-4214-A4A0-4BBCB1057717Q40596585-62D847F7-DA94-4AC2-AD19-87703761769BQ40597614-2D97B22C-7CD7-4CDE-BC1D-CB20085288D8Q41687005-EDE8AB8C-E89E-4329-A831-5010266BFD5FQ41872428-E01F63D4-9F41-4D24-8B21-1E4CCFEDAA06Q43937776-17E498B9-BA97-4FF7-8AA4-205093AF7D13Q44401570-AB11CFC3-51F0-49E2-9FCA-28F4A8F1B321Q45330205-5B48AD3F-980C-4A02-B5BB-9769669E5867
P2860
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
@en
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
@nl
type
label
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
@en
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
@nl
prefLabel
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
@en
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
@nl
P2860
P356
P1476
Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
@en
P2093
John Brazier
P2860
P2888
P356
10.1186/1477-7525-7-27
P577
2009-03-31T00:00:00Z
P5875
P6179
1037384833